Back to Search Start Over

A Phase I/II Trial of Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy for Previously Treated Patients with CLL,

Authors :
Wierda, William G.
Balakrishnan, Kumudha
Ferrajoli, Alessandra
Kadia, Tapan
Cortes, Jorge E.
O'Brien, Susan
Burger, Jan A.
Tambaro, Francesco Paolo
Jalayer, Annette
Lerner, Susan
Keating, Michael J
Gandhi, Varsha
Source :
Blood; November 2011, Vol. 118 Issue: 21 p3901-3901, 1p
Publication Year :
2011

Abstract

No relevant conflicts of interest to declare.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
118
Issue :
21
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs52982255
Full Text :
https://doi.org/10.1182/blood.V118.21.3901.3901